Keck School of Medicine of USC

Keck School of Medicine of USC

We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.

 

Keck School of Medicine of USC
K

Use of Genomic Assays in Managing Early Stage HR+/HER2- BC

By Keck School of Medicine of USC FEATURING Kevin Kalinsky
By Keck School of Medicine of USC FEATURING Kevin Kalinsky
41 views
February 22, 2023
0 Comments
Login to view comments. Click here to Login
10th Annual USC Multi-Disciplinary Breast Cancer Symposium
31:03
Keck School of Medicine of USC

Inflammatory Breast Cancer: How Can We Improve Outcomes?

Feat. A. Lucci
23:30
Keck School of Medicine of USC

Outcomes of Vascularized Submental Lymph Node Flap Transfer for Brea…

Feat. M. Cheng
25:02
Keck School of Medicine of USC

2023 Updates on Breast Cancer in Young Women

Feat. K. Ruddy
32:59
Keck School of Medicine of USC

Evolving Strategies in TNBC in 2023

Feat. M. Pegram
27:25
Keck School of Medicine of USC

Use of Genomic Assays in Managing Early Stage HR+/HER2- BC

Feat. K. Kalinsky
29:53
Keck School of Medicine of USC

Advances in Treatment of HER2+ BC in 2023

Feat. W. Gradishar
27:45
Keck School of Medicine of USC

Oncofertility Considerations in Young Breast Cancer Survivors

Feat. I. Su